Page last updated: 2024-09-02

ecteinascidin 743 and Lung Neoplasms

ecteinascidin 743 has been researched along with Lung Neoplasms in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (5.26)18.2507
2000's7 (36.84)29.6817
2010's7 (36.84)24.3611
2020's4 (21.05)2.80

Authors

AuthorsStudies
Avendaño, C; de la Cuesta, E; González, JF1
Avendaño, C; Cuesta, Ede L; González, JF; Manguan-García, C; Ortín, I; Perona, R1
Cao, D; Gao, Z; Lin, C; Lin, Y; Liu, H; Liu, SL; Luo, L; Ma, W; Shi, Y; Wang, J; Wang, P; Wang, W; Xiang, Q; Xu, W; Zeng, Z; Zhao, Y1
Cai, S; Ding, Z; Liu, X; Zeng, J1
Chiba, K; Horiuchi, K; Inoue, M; Ishizaka, T; Matsuhashi, Y; Rikitake, H; Susa, M; Taguchi, E1
Reichardt, P1
Bongiovanni, L; Botti, L; Burocchi, A; Cancila, V; Cappetti, B; Chiodoni, C; Colombo, MP; Galvan, S; Garofalo, C; Manara, MC; Parenza, M; Ratti, C; Sangaletti, S; Scotlandi, K; Torselli, I; Tripodo, C; Valenti, CF1
Aglietta, M; Aliberti, S; Galizia, D; Grignani, G; Nuzzo, AM; Palesandro, E; Pignochino, Y1
Basso, U; Maruzzo, M; Montesco, MC; Rastrelli, M; Roma, A; Zanardi, E1
Grignani, G; Martín-Broto, J; Reichardt, P; Schuler, M1
Capri, G; Corradino, I; Cresta, S; D'Incalci, M; De Braud, F; Gallerani, E; Gianni, L; Locatelli, A; Marsoni, S; Minoia, C; Noberasco, C; Sessa, C; Zintl, P; Zucchetti, M1
Croué, A; Pavageau, AH; Reguerre, Y; Rialland, X; Rousselet, MC1
Contreras Ibáñez, JA; Díaz Gómez, L; Navas García, N1
Alberola, V; Alfaro, V; Camps, C; Cobo, M; Dómine, M; Gutiérrez-Calderón, V; Isla, D; Lardelli, P; Massuti, B; Nieto, A; Provencio, M; Rosell, R; Tarón, M; Viñolas, N1
De Pooter, CM; Faircloth, GT; Korst, AE; Lambrechts, HA; Lardon, F; Pattyn, GG; Simoens, C; Vermorken, JB1
Beijnen, JH; Beumer, JH; Lopez-Lazaro, L; Rademaker-Lakhai, JM; Rosing, H; Schellens, JH1
Brain, E; Jimeno, J; Misset, JL; Riofrio, M; Spielmann, M; Taamma, A; Turpin, F; Yovine, A; Zelek, L1
Cowan, C; Koontz, MZ; Monk, BJ; Saffari, B; Tewari, D; Wallick, AC1
Faircloth, GT; Fiebig, HH; Giavazzi, R; Hendriks, HR; Jimeno, JM; Langdon, SP1

Reviews

2 review(s) available for ecteinascidin 743 and Lung Neoplasms

ArticleYear
Trabectedin in Cancers: Mechanisms and Clinical Applications.
    Current pharmaceutical design, 2022, Volume: 28, Issue:24

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carcinoma, Non-Small-Cell Lung; Dioxoles; Humans; Lung Neoplasms; Sarcoma; Trabectedin; Tumor Microenvironment

2022
Prolonged disease stability with trabectedin in a heavily pretreated elderly patient with metastatic leiomyosarcoma of the thigh and renal failure: a case report and review of the literature.
    Oncology research, 2013, Volume: 20, Issue:10

    Topics: Aged; Antineoplastic Agents, Alkylating; Dioxoles; Disease Progression; Humans; Leiomyosarcoma; Lung Neoplasms; Male; Renal Insufficiency; Salvage Therapy; Tetrahydroisoquinolines; Time Factors; Tomography, X-Ray Computed; Trabectedin; Treatment Outcome

2013

Trials

4 trial(s) available for ecteinascidin 743 and Lung Neoplasms

ArticleYear
Phase I clinical and pharmacokinetic study of trabectedin and cisplatin in solid tumours.
    European journal of cancer (Oxford, England : 1990), 2009, Volume: 45, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dioxoles; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Neutropenia; Ovarian Neoplasms; Tetrahydroisoquinolines; Trabectedin

2009
Trabectedin in patients with advanced non-small-cell lung cancer (NSCLC) with XPG and/or ERCC1 overexpression and BRCA1 underexpression and pretreated with platinum.
    Lung cancer (Amsterdam, Netherlands), 2012, Volume: 76, Issue:3

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; BRCA1 Protein; Carcinoma, Non-Small-Cell Lung; Dioxoles; DNA-Binding Proteins; Endonucleases; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nuclear Proteins; Platinum; Tetrahydroisoquinolines; Trabectedin; Transcription Factors; Treatment Outcome

2012
Trabectedin (Yondelis, formerly ET-743), a mass balance study in patients with advanced cancer.
    Investigational new drugs, 2005, Volume: 23, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Area Under Curve; Carbon Radioisotopes; Carcinoma, Non-Small-Cell Lung; Dioxoles; Feces; Female; Half-Life; Humans; Isoquinolines; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Sarcoma; Sarcoma, Synovial; Tetrahydroisoquinolines; Trabectedin

2005
A phase II study of Yondelis (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer.
    British journal of cancer, 2006, Jun-05, Volume: 94, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Breast Neoplasms; Dioxoles; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Isoquinolines; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Tetrahydroisoquinolines; Trabectedin

2006

Other Studies

13 other study(ies) available for ecteinascidin 743 and Lung Neoplasms

ArticleYear
Synthesis and cytotoxic activity of pyrazino[1,2-b]-isoquinolines, 1-(3-isoquinolyl)isoquinolines, and 6,15-iminoisoquino[3,2-b]-3-benzazocines.
    Bioorganic & medicinal chemistry, 2007, Jan-01, Volume: 15, Issue:1

    Topics: Azocines; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Screening Assays, Antitumor; Humans; Isoquinolines; Lung Neoplasms; Molecular Conformation; Pyrazines; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured

2007
Pyrazino[1,2-b]isoquinolines: synthesis and study of their cytostatic and cytotoxic properties.
    Bioorganic & medicinal chemistry, 2008, Oct-01, Volume: 16, Issue:19

    Topics: Adenocarcinoma; Apoptosis; Cell Cycle; Cell Division; Cell Line, Tumor; Cytostatic Agents; DNA Damage; G1 Phase; G2 Phase; HT29 Cells; Humans; Inhibitory Concentration 50; Isoquinolines; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Pyrazines; S Phase; Structure-Activity Relationship

2008
Trabectedin induces ferroptosis via regulation of HIF-1α/IRP1/TFR1 and Keap1/Nrf2/GPX4 axis in non-small cell lung cancer cells.
    Chemico-biological interactions, 2023, Jan-05, Volume: 369

    Topics: Carcinoma, Non-Small-Cell Lung; Ferroptosis; Humans; Iron; Kelch-Like ECH-Associated Protein 1; Lung Neoplasms; NF-E2-Related Factor 2; Reactive Oxygen Species; Trabectedin

2023
Trabectedin suppresses osteosarcoma pulmonary metastasis in a mouse tumor xenograft model.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2022, Volume: 40, Issue:4

    Topics: Adolescent; Animals; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Heterografts; Humans; Lung Neoplasms; Mice; Neoplasm Metastasis; Osteosarcoma; Trabectedin

2022
Uncertainties that threaten the benefit/risk balance in early treatment lines for advanced or metastatic soft tissue sarcoma.
    Future oncology (London, England), 2021, Volume: 17, Issue:21s

    Topics: Aged, 80 and over; Chemoradiotherapy; Disease Progression; Fatal Outcome; Humans; Leiomyosarcoma; Lumbar Vertebrae; Lung; Lung Neoplasms; Male; Positron Emission Tomography Computed Tomography; Risk Assessment; Spinal Neoplasms; Trabectedin

2021
Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2017, Sep-01, Volume: 23, Issue:17

    Topics: Bone Neoplasms; Cell Differentiation; Cell Line, Tumor; Cellular Reprogramming; Core Binding Factor Alpha 1 Subunit; Dioxoles; Humans; Immunotherapy; Lung Neoplasms; Osteosarcoma; Programmed Cell Death 1 Receptor; T-Lymphocytes; Tetrahydroisoquinolines; Trabectedin; Tumor Microenvironment; Tumor Suppressor Protein p53

2017
Response to trabectedin in a patient with advanced synovial sarcoma with lung metastases.
    Anti-cancer drugs, 2014, Volume: 25, Issue:10

    Topics: Adult; Antineoplastic Agents; Axilla; Combined Modality Therapy; Dioxoles; Epirubicin; Fatal Outcome; Humans; Ifosfamide; Lung Neoplasms; Male; Niacinamide; Phenylurea Compounds; Sarcoma, Synovial; Sorafenib; Tetrahydroisoquinolines; Trabectedin

2014
Trabectedin clinical cases: use according to indication in diverse clinical scenarios.
    Future oncology (London, England), 2015, Volume: 11, Issue:11 Suppl

    Topics: Anthracyclines; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Contraindications; Dacarbazine; Deoxycytidine; Dioxoles; Female; Femoral Neoplasms; Gemcitabine; Humans; Hysterectomy; Ifosfamide; Leiomyosarcoma; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Radionuclide Imaging; Remission Induction; Salvage Therapy; Sarcoma; Sarcoma, Synovial; Soft Tissue Neoplasms; Tetrahydroisoquinolines; Thigh; Tomography, X-Ray Computed; Trabectedin; Treatment Outcome; Uterine Neoplasms

2015
[A rare tumour with a distinctive histological appearance].
    Annales de pathologie, 2010, Volume: 30, Issue:2

    Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Arteriovenous Malformations; Bevacizumab; Biomarkers, Tumor; Combined Modality Therapy; Dactinomycin; Desmin; Diagnosis, Differential; Dioxoles; Doxorubicin; Humans; Ifosfamide; Leg; Lung Neoplasms; Male; Neoplasm Proteins; Prognosis; S100 Proteins; Sarcoma, Alveolar Soft Part; Soft Tissue Neoplasms; Staining and Labeling; Tetrahydroisoquinolines; Trabectedin; Vincristine

2010
Mestastatic gastric cancer from malignant fibrous histiocytoma.
    Revista espanola de enfermedades digestivas, 2011, Volume: 103, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Dioxoles; Docetaxel; Epirubicin; Fatal Outcome; Gemcitabine; Histiocytoma, Malignant Fibrous; Humans; Ifosfamide; Lung Neoplasms; Male; Soft Tissue Neoplasms; Spinal Neoplasms; Stomach Neoplasms; Taxoids; Tetrahydroisoquinolines; Thigh; Thoracic Vertebrae; Trabectedin

2011
In vitro interaction between ecteinascidin 743 (ET-743) and radiation, in relation to its cell cycle effects.
    British journal of cancer, 2003, Dec-15, Volume: 89, Issue:12

    Topics: Antineoplastic Agents, Alkylating; Carcinoma; Cell Cycle; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Dioxoles; Humans; Isoquinolines; Lung Neoplasms; Radiation-Sensitizing Agents; Tetrahydroisoquinolines; Tongue Neoplasms; Trabectedin; Urinary Bladder Neoplasms

2003
Activity of trabectedin (ET-743, Yondelis) in metastatic uterine leiomyosarcoma.
    Gynecologic oncology, 2006, Volume: 102, Issue:3

    Topics: Adult; Antineoplastic Agents, Alkylating; Dioxoles; Drug Administration Schedule; Drugs, Investigational; Female; Humans; Leiomyosarcoma; Lung Neoplasms; Neoplasm Recurrence, Local; Tetrahydroisoquinolines; Trabectedin; Uterine Neoplasms

2006
High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:10

    Topics: Adult; Animals; Antineoplastic Agents, Alkylating; Carcinoma, Non-Small-Cell Lung; Dioxoles; Female; Humans; Isoquinolines; Lung Neoplasms; Male; Melanoma; Mice; Mice, Nude; Middle Aged; Neoplasm Transplantation; Ovarian Neoplasms; Tetrahydroisoquinolines; Trabectedin

1999